10-2-1 Strategic Plan

Implement the "10-2-1 Chinese Breast Milk Source Strain Strategic Plan", advancing the inclusion of Chinese breast milk source strains into the list of usable strains for infant food at a rate of one strain every two years. This aims to break the monopoly of foreign strains (currently, foreign strains occupy 85% of the Chinese infant probiotic market). Several strains have been developed, such as BL-11 (for children's development), LR99 (for mental health), and WIS32 (fermented lactic acid bacteria). Through a three-step strategy of "exclusive resource - technological breakthrough - standard leadership", the "Chinese gene" has been implanted in the underlying framework of microecological medicine.